BioPharma Credit (BPCR)

Index:

FTSE 250

$ 0.98
   
  • Change Today:
    $0.00
  • 52 Week High: $0.9
  • 52 Week Low: $0.8
  • Currency: US Dollars
  • Shares Issued: 1,122.19m
  • Volume: 1,320,115
  • Market Cap: $1,099.75m
  • RiskGrade: 32
  • Beta: 0.00

BPCR Overview

BioPharma Credit plc provides investors with an opportunity to gain exposure to the fast growing life sciences industry, through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. BioPharma Credit’s primary objective is to generate predictable income for shareholders over the long term.

Key Personnel

Chairman: Harry Abraham Hyman
Independent Non-Executive Director: Stephanie Léouzon
Independent Non-Executive Director: Rolf Soderstrom
Senior Independent Director: Sapna Shah
Non-Executive Dir: Nigel Reynolds, Graeme Proudfoot

Contact Details

Address: 19th Floor, 51 Lime Street, London, United Kingdom, EC3M 7DQ
Phone: +44 (0)1392 477500
Website: http://www.bpcruk.com

Listings

Index: FTSE 250, FTSE 350, FTSE All-Share
Domestic Listings: LSE:BPCP
ISIN: GB00BDGKMY29

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

BPCR Market Data

Currency US Dollars
Share Price $ 0.98
Change Today $ 0.00
% Change 0.20 %
52 Week High $0.9
52 Week Low $0.8
Volume 1,320,115
Shares Issued 1,122.19m
Market Cap $1,099.75m
Beta 0.00
RiskGrade 32

BPCR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

BPCR Dividends

  Latest Previous
  3rd Interim 2nd Interim
Ex-Div 08-Oct-26 02-Jul-26
Paid 06-Nov-26 31-Jul-26
Amount 1.75¢ 1.75¢

Trades for 02-Oct-2026

Time Volume / Share Price
16:35 27,201 @ $0.98
16:35 407,838 @ $0.98
16:35 100,571 @ $0.98
16:35 1,376 @ $0.98
16:35 1,177 @ $0.98

BPCR Key Personnel

Chair Harry Abraham Hyman

Top of Page